Sikarin Public Company (SKR) Fair Value & Analysis
Healthcare · TH · Market cap 16.2B THB
Fair value as of: Jul 16, 2026
From 26 valuation models · updated 25 days ago
Fair value updated Jul 16, 2026, revised from 8.15 THB to 7.95 THB (−2.5%) since Jun 24, 2026. Share price −1.2% over the past month.
A solid business, currently priced close to our fair value.
What matters now
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
- Our model range runs from 5.99 THB (bear) to 9.92 THB (bull), base 7.95 THB. The closer the price sits to the lower half, the larger the margin of safety.
- Quality 71/100 (solid quality) with high evidence: the data supports the verdict.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 16, 2026.
How to read this chart
60‑month range 6.12 THB – 14.04 THB · fair‑value band 5.99 THB – 9.92 THB · the 8.00 THB price screens above the 7.95 THB fair value. Dashed = 300-day average. As of Jul 16, 2026.
Analysis
Sikarin Public Company (SKR) currently trades at 8.00 THB, while our model-based Fair Value estimate is 7.95 THB, implying the stock looks roughly 0.6% fairly valued today. The Quality Score stands at 71/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Sikarin Public Company generated revenue of 5.9B THB at a net margin of 11.3%. Revenue declined 8.3% year over year. It earns a return on equity of 8.4%. The balance sheet holds a net cash position of 176M THB. Fundamentals as of Jul 16, 2026
Our scenario range runs from 5.99 THB (bear case) to 9.92 THB (bull case); at 8.00 THB, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 1% below its 52-week high and 33% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 11% fair-value upside, at -1%, SKR screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 26 models by family
Widest divergence: DCF Models (10.16 THB) versus Asset-Based (2.59 THB). Highest evidence: Growth DCF (80).
Notify me when SKR reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 16, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 71 · Market factors (momentum, volatility) 67
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Sikarin Public Company Limited, together with its subsidiaries, operates hospitals in Thailand. The company operates diabetes and endocrine center, general medicine clinic, emergency and trauma center, surgery clinic, children's dental center, aesthetic center, laboratory department, diagnostic radiology center, CT scan unit, operating rooms, hemodialysis …
Full company description
Sikarin Public Company Limited, together with its subsidiaries, operates hospitals in Thailand. The company operates diabetes and endocrine center, general medicine clinic, emergency and trauma center, surgery clinic, children's dental center, aesthetic center, laboratory department, diagnostic radiology center, CT scan unit, operating rooms, hemodialysis units, physical therapy department with physical medicine and rehabilitation specialist, catheter laboratory, intensive care units, coronary care units, inpatient wards and international wards, after heart and thoracic surgery ward, medical-surgical ward, and pediatric ward. It also operates woman's health center, health center, fertility center, delivery room, nursery department and the inpatient wards, obstetrics and gynecology ward, stroke center, EENT center, international medical center, orthopedics center, and MRI center. In addition, the company is involved in the management of rental spaces; and sale of food and beverages, as well as restaurant and medical clinic business. The company was founded in 1979 and is headquartered in Bangkok, Thailand.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Sikarin Public Company reported revenue of 6.0B THB in FY2025 versus 6.4B THB in FY2021, a compound −1.2%/yr. Reported net income was 752M THB in FY2025, compounding −14.3%/yr from FY2021.
of which total revenue +12.3 pp · buybacks/dilution −3.6 pp
Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).
Watch SKR: get an alert when its fair value changes →
Peer Group
Medical Care Facilities · 261 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 16, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $378.85 | $554.93 | +46% |
| Fresenius SE FRE | €41.73 | €32.15 | -23% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.58 SGD | 1.44 SGD | -44% |
| Tenet Healthcare Corporation THC | $194.91 | $338.05 | +73% |
| Rede D'Or São Luiz S.A RDOR3 | R$36.01 | R$47.31 | +31% |
| DaVita Inc DVA | $231.61 | $255.97 | +11% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,955 | ₹2,955 | -67% |
| Fresenius Medical Care AG FMS | $24.68 | $45.60 | +85% |
| Aier Eye Hospital Group 300015 | ¥8.68 | ¥7.67 | -12% |
Compare Sikarin Public Company with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Sikarin Public Company (SKR) overvalued or undervalued?
What is the fair value of SKR?
What is the quality score of SKR?
What is the revenue of Sikarin Public Company (SKR)?
What is the net profit margin of SKR?
Does Sikarin Public Company pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Sikarin Public Company and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.